Last reviewed · How we verify

IV Iron (standard of care) — Competitive Intelligence Brief

IV Iron (standard of care) (IV Iron (standard of care)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement therapy. Area: Hematology.

phase 3 Iron replacement therapy Hematology Small molecule Live · refreshed every 30 min

Target snapshot

IV Iron (standard of care) (IV Iron (standard of care)) — Nicoletta C Machin. IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
IV Iron (standard of care) TARGET IV Iron (standard of care) Nicoletta C Machin phase 3 Iron replacement therapy
Supplementation of iron sucrose Supplementation of iron sucrose Medical University of Vienna marketed Iron replacement therapy
Parentral Iron Parentral Iron Services Institute of Medical Sciences, Pakistan marketed Iron replacement therapy
Low Molecular Weight Iron Dextran Low Molecular Weight Iron Dextran University of Washington marketed Iron replacement therapy
Iron-Dextran Complex Injection [InFed] Iron-Dextran Complex Injection [InFed] Oregon Health and Science University marketed Iron replacement therapy
IV iron infusion IV iron infusion NICHD Global Network for Women's and Children's Health marketed Iron replacement therapy
IV iron - Sodium Ferric Gluconate Complex IV iron - Sodium Ferric Gluconate Complex Rambam Health Care Campus marketed Iron replacement therapy Iron (Fe3+) delivery to erythropoietic tissues

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement therapy class)

  1. AMAG Pharmaceuticals, Inc. · 1 drug in this class
  2. Medical University of Vienna · 1 drug in this class
  3. NICHD Global Network for Women's and Children's Health · 1 drug in this class
  4. Nicoletta C Machin · 1 drug in this class
  5. Oregon Health and Science University · 1 drug in this class
  6. Pharmacosmos A/S · 1 drug in this class
  7. Rambam Health Care Campus · 1 drug in this class
  8. Services Institute of Medical Sciences, Pakistan · 1 drug in this class
  9. Sumitomo Pharma America, Inc. · 1 drug in this class
  10. University of Washington · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IV Iron (standard of care) — Competitive Intelligence Brief. https://druglandscape.com/ci/iv-iron-standard-of-care. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: